Atlas Trials

A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer

Clinical trial NCT03013712 · UNKNOWN

Trial details

NCT number
NCT03013712
Sponsor
First Affiliated Hospital of Chengdu Medical College
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Colon CancerEsophageal CarcinomaPancreatic CancerProstate CancerGastric CancerHepatic Carcinoma
Start date
2017-01-01
Primary completion
2018-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.